Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trialLore Vanderbeke, Oscar Hoiting, Tom F.W. Wolfs et al.|Intensive Care Medicine|2021Cited by 98